These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18192825)

  • 1. Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage.
    Mancia G; Zanchetti A;
    J Hypertens; 2008 Feb; 26(2):164-8. PubMed ID: 18192825
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the usage of antihypertensive drugs: implications and prospects.
    Schachter M
    Br J Clin Pharmacol; 2005 Sep; 60(3):231-4. PubMed ID: 16120060
    [No Abstract]   [Full Text] [Related]  

  • 3. Between-country variation in the utilization of antihypertensive agents: Guidelines and clinical practice.
    Stolk P; Van Wijk BL; Leufkens HG; Heerdink ER
    J Hum Hypertens; 2006 Dec; 20(12):917-22. PubMed ID: 16988753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recently published European and American guidelines for the diagnosis and treatment of hypertension].
    van Zwieten PA; Struijker Boudier HA; de Leeuw PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):868-71. PubMed ID: 15152386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockade should not be among several choices for initial therapy of hypertension.
    Opie LH
    J Hypertens; 2008 Feb; 26(2):161-3. PubMed ID: 18192824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?].
    Zidek W
    MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867
    [No Abstract]   [Full Text] [Related]  

  • 7. An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece.
    Stafilas PC; Sarafidis PA; Lasaridis AN; Aletras VH; Niakas DA
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1233-40; discussion 1241-2. PubMed ID: 16182115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating hypertension in patients with ischaemic disease: the case for better beta-blocker usage.
    Cardiovasc J Afr; 2008; 19(2):113. PubMed ID: 18516359
    [No Abstract]   [Full Text] [Related]  

  • 9. Profile of antihypertensive prescription in a developing country.
    Alebiosu CO
    Trop Doct; 2006 Jan; 36(1):44-6. PubMed ID: 16483436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire.
    Olsen MH; Mallion JM; Rahn KH; Erdine S; Viigimaa M; Laurent S; Agabiti-Rosei E; Mancia G; Schmieder RE; Cifkova R; Dominiczak A; Kjeldsen SE; Redon J; Zanchetti A; Nilsson P; Narkiewicz K;
    J Hypertens; 2010 Jul; 28(7):1593-4. PubMed ID: 20574253
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulse pressure, central blood pressure and beta blockaders in disgrace. The Danish Society of Hypertension].
    Andersen NH; Knudsen ST; Hansen KW;
    Ugeskr Laeger; 2007 Mar; 169(12):1108. PubMed ID: 17394819
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertension control rates: time for translation of guidelines into clinical practice.
    Hart PD; Bakris GL
    Am J Med; 2004 Jul; 117(1):62-4. PubMed ID: 15210392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Do we need a new strategy in hypertension treatment?].
    Beaufils M
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):630-5. PubMed ID: 12555469
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockers should remain as first-line therapy in the management of hypertension.
    Krum H
    Int J Clin Pract; 2008 Aug; 62(8):1137-41. PubMed ID: 18705818
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-blockers and the treatment of hypertension.
    Williams B
    J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming trial results into practice change: the final translational hurdle: Comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use".
    Avorn J
    Arch Intern Med; 2010 May; 170(10):858-60. PubMed ID: 20498412
    [No Abstract]   [Full Text] [Related]  

  • 19. Hospitals boost performance with beta blocker data.
    Data Strateg Benchmarks; 2001 Oct; 5(10):149-51, 145. PubMed ID: 11682807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do we overtreat hypertension?
    Spence D
    BMJ; 2012 Sep; 345():e5923. PubMed ID: 22951565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.